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TRIPATHI eT Al.
| INTRODUC TI ON
Hypertrophic cardiomyopathy (HCM) is a complex genetically transmitted disease with variable clinical expression. 1, 2 Since its initial presentation more than 50 years ago, HCM is considered as a major cause of sudden cardiac death (SCD), heart failure (HF), AF and stroke. 3, 4 HCM often takes insidious clinical course, and early detection may be beneficial for prevention of significant morbidity and mortality in high-risk patients. Consequently, there is an ever growing effort to study the frequency of HCM in the general population. 5 However, most of the natural history data of HCM are derived from regional cohorts, [6] [7] [8] and thus comprehensive assessment of disease in various age groups and patients with different ethnicity remains incomplete. More importantly, there is paucity of epidemiological information with regards to HCM and concomitant arrhythmia, which is the main trigger for mortality in these patients. To fill this knowledge gap, we studied the temporal trends in HCM related hospitalization in the United States (US), while keeping the main focus on patients with HCM and associated burden of arrhythmia.
This study also covers the important aspects of disease burden in terms of inhospital mortality, comorbidities, length of hospital stay (LOS) and cost of caring during the hospitalization.
| ME THODS
We acquired data using Nationwide Inpatient Sample (NIS) from the year 2003 to 2014. NIS is the largest database of hospital inpatient stays in the United States (US), generated by the Agency for
Healthcare Research and Quality (AHRQ). This database accounts
for approximately up to 8 million discharges each year; and has been used in the past for ascertainment, tracking, and assessment of national trends in health care provision, access, major procedures related outcomes, disparity of care, hospitalizations rates, and analysis of health care economics and quality control measures. [9] [10] [11] [12] Each individual hospitalization in NIS is deidentified and kept as a unique entry with one primary discharge diagnosis and < 29 secondary diagnoses during that hospitalization. Internal validity of the database is maintained by performing annual data quality assessments, while the external validity of this database is evaluated by comparing with the National Hospital Discharge Survey from the National Center for Health Statistics, American Hospital Association Annual Survey
Database, and the MedPAR inpatient data from the Centers for
Medicare and Medicaid Services.
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In this cross sectional study, we studied all hospitalizations from 2003 to 2014 using the ICD-9 codes 425.1 and 425.11 for hypertrophic cardiomyopathy (HCM) in all diagnosis fields. We included all the subjects ≥ 18 years. To study the baseline characteristics, we excluded subjects with missing information, such as, age, gender, admission or discharge date, and inpatient mortality status. For the purpose of potential confounder identification, both patient-and hospital-level variables were included. The severity of comorbid conditions was defined using Deyo modification of Charlson comorbidity index 14 (Table S1 ). This index contains 17 comorbid conditions with differential weights. The score ranges from 0 to 33, with higher scores corresponding to greater burden of comorbid diseases. We identified heart failure and renal failure using "cm_" variables provided by NIS. We defined arrhythmias as codiagnosis of any of any of these specific rhythm disorders: Atrial fibrillation, Atrial Flutter, Supraventricular tachycardia, Ventricular Fibrillation/Flutter, or Ventricular Tachycardia. These specific arrhythmias were identified using ICD-9 codes in any diagnosis field (Table S2) 18 Differences between categorical variables were tested using the chi-square test, and differences between continuous variables were tested using the student's t test. All the analyses were performed at 5% significance level. 
| RE SULTS

| HCM hospitalization, demographics and comorbidities
| Trends of arrhythmia in HCM patients
| Trends of specific arrhythmias among HCM patients
Among HCM subjects, 40.3% of patients had a wide range of arrhythmia at presentation. Specifically, AF (34.1%) was the most commonly reported arrhythmia followed by ventricular tachycardia (6.7%) and atrial flutter (4.4%). Across all the arrhythmias, AFL
showed the maximum increase in prevalence across the study period (relative increase 65.7%, P < 0.001), followed by VT (relative increase 30.1%, P < 0.001), VT/VFL (relative increase 26.7%, P < 0.001) and AF (relative increase 22.1%, P < 0.001) (Figure 1 ).
| Mortality trends among HCM patients with arrhythmias
Although inhospital mortality was higher in HCM patients with concomitant arrhythmia, there was a significant decline in mortality in patients with arrhythmia from 6.2 % in 2003 to 3.4 % in 2014 (relative decrease 22.82%, P-trend < 0.001). Mortality rate was higher in patients ≥ 80 years age (7.4%), females (5.5%), and black population (4.64%) among HCM patients with arrhythmias. Mortality was slightly lesser in teaching hospitals than nonteaching hospitals (4.4% TA B L E 2 (Continued) vs 4.8%, P < 0.001); conversely, mortality rates were higher in West region hospitals (5.6%) and in patients with Medicare/Medicaid insurance (5.3%). Mortality was higher for patients carrying HF (9.5%) and renal failure (8.1%) as comorbid diagnosis compared to those who did not have these comorbidities. Trends of mortality in specific subgroups of HCM patients with arrhythmias are shown in Table 3 .
Among specific arrhythmias in HCM patients, highest mortality was observed in patients with VF/VFL (18.3 %), AF and VT (4.5%) and atrial flutter (4.1%).However, there was a gradual reduction in arrhythmia specific mortality, and statistically significant reduction occurred in VF/VFL (relative decrease 44.5%, P-trend < 0.001) and AF (relative decrease 29.3%, P-trend < 0.001) (Table 4) .
| Cost trends (USD) in HCM patients with arrhythmias
Among HCM patients with arrhythmias, after adjustment for infla- Table S3 .
Overall mean cost of HCM hospitalization was consistently higher if patients had any type of arrhythmia compared to no arrhythmia ($20522 vs $15636). Across all arrhythmias, the mean cost of care was highest if subjects had VF/VFL ($39108) and ventricular tachycardia ($28996), while, the increase in trend of cost of care was highest for supraventricular tachycardia throughout the study period (relative increase 45.4%, P-trend < 0.04) ( Table 5 ). Arrhythmia specific trend in length of hospitalization is shown in Table S4 .
| D ISCUSS I ON
In this study of contemporary data of HCM related hospitalization in USA, we report that over 11 years (2003-2014) , there was an increase in hospitalization rates in patients with HCM and concurrent arrhythmia. Patients 65 years of age or older were admitted most frequently. Overall in HCM, females were dominant over males, and thus had comparatively a higher prevalence of mortality and LOS, however we noted higher prevalence of a, c, d, e, f, g = Same as Table 1 .
TA B L E 3 (Continued)
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TA B L E 4 Trends of mortality as per specific arrhythmia in hospitalized HOCM patients Other primary diagnosis: derived from appropriate ICD 9CM code mentioned in Table S2 .
arrhythmias associated with HCM among male patients compared to females. AF was the most commonly reported arrhythmia and AFL exhibited a substantial increase in prevalence compared to all other arrhythmias. Compared to HCM patients without arrhythmias, inhospital mortality was significantly higher in those with arrhythmia, with VF related SCD as the main contributor in mortality. However, there was a trend towards reduction in mortality throughout the study periods, and in fact the highest mortality reduction occurred in VF victims. The mortality was significantly higher in patients carrying codiagnosis of HF and renal failure.
The cost of care increased significantly over the entire study duration, and admissions with renal failure and HF claimed for the highest cost of care. Insignificant reduction in length of stay was noted during study period (Table S2 ).
Besides endorsing various former studies, these observations highlight some new epidemiological trends in HCM patients.
Higher prevalence of HCM among women has been consistently reported in prior reports, 3, 6, 19 with most patients surviving to advanced ages (>80 years) 23, 24 .
Our study reports lesser mortality in relatively younger age groups and more admission rates among old age patients. These findings validate some of the recently published reports. AF is the most commonly associated supraventricular arrhythmia in HCM. 35 In analysis of Italian and US cohorts, AF was found be a strong predictor of mortality in HCM (odds ratio (OR): 3.7; P < 0.002) secondary to severe HF related death. 35 This risk was greater in patients < 50 years of age with left ventricular outlet obstruction.
Another Japanese study showed that incidence of AF was most important predictor of cardiovascular mortality in HCM patients.
36
These findings from our analysis are supported by results published in previous studies. Consistent with general reduction in mortality, AF related mortality in HCM has also reduced due to previously discussed better clinical practices which have led to extended longevity in these subsets of patients.
Our study explored the cost burden associated with management of HCM patients with arrhythmias, noting approximately 34.5% rise during the study period. Despite no significant change in the length of hospitalization, healthcare burden significantly rose during the study period approximating 160 million USD per annum.
This overwhelming rise in cost of care not only reflects the increasing utilization of expensive technologies such as catheter ablation and devices in the management of these high-risk subjects but also points towards the growing prevalence of arrhythmias in HCM patients. In the context of ever growing burden on public health and its associated cost of care, these observations are alarming and deserve serious consideration. 
| LI M ITATI O N S
This study has limitations inherent to administrative databases.
Although administrative databases are increasingly used for representing the scientific information, such studies are prone to errors secondary to coding inaccuracies. HCM and related comorbidities were diagnosed based on administrative codes. Therefore, there is a possibility that we might have missed some information, leading to under estimation of the number of hospitalizations. Given the nature of the data, we could only examine inhospital mortality; hence, the study lacks the assessment of long-term follow-up outcomes.
| CON CLUS ION
Our study reports rise in hospitalization as a result of arrhythmias in HCM patients as well as concurrent increase in mortality and resource utilization over study period. We believe that this study represents new epidemiological trends. Furthermore, inclusion of a "real-world" large sample size and the absence of selection bias have strengthened the validity of the outcomes.
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